Sulfadiazine

Sulfadiazine

SCHEMBL18668477

Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1.[Ag].[Zn]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfadiazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.93
AURKA O14965 1/20 0.93
DHFR P00374 1/20 0.93
TSHR P16473 1/20 0.93
SMN1; SMN2 Q16637 2/20 0.64
CYP2C9 P11712 2/20 0.63
MAPT P10636 2/20 0.63
ALDH1A1 P00352 4/20 0.58
TDP1 Q9NUW8 3/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 1/20 0.56
CYP3A4 P08684 1/20 0.55
L3MBTL1 Q9Y468 3/20 0.55
PRMT1 Q99873 1/20 0.55
KDM4E B2RXH2 2/20 0.54
EDNRA P25101 1/20 0.54
SLC6A4 P31645 1/20 0.54
ADRA1A P35348 1/20 0.54
PRMT6 Q96LA8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfadiazine SCHEMBL34517 0.98 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL4098255 0.98 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL570072 0.98 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL3274530 0.98 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL16860643 0.98 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL27795518 0.97 LMNA (0.93) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL10422849 0.96 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL24176 0.96 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL30080807 0.96 LMNA (1.00) LMNAAURKADHFRTSHRSMN1; SMN2
Sulfadiazine SCHEMBL5870705 0.95 LMNA (0.96) LMNAAURKADHFRTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114533655-A Improved sulfadiazine zinc-silver cream and preparation method thereof 中国人民武装警察部队特色医学中心 2022-05-27 CN disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
EP-3352805-B1 A NOVEL PHARMACEUTICAL WOUND HEALING COMPOSITION COUNCIL SCIENT IND RES (IN) 2020-09-02 EP disclosed
US-10709743-B2 Pharmaceutical wound healing composition COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-07-14 US disclosed
WO-2018204764-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION (US) 2018-11-08 WO disclosed
US-20180264051-A1 A NOVEL PHARMACEUTICAL WOUND HEALING COMPOSITION COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2018-09-20 US disclosed
EP-3352805-A1 A NOVEL PHARMACEUTICAL WOUND HEALING COMPOSITION Council of Scientific and Industrial Research (IN) 2018-08-01 EP disclosed
WO-2017051433-A1 A NOVEL PHARMACEUTICAL WOUND HEALING COMPOSITION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-03-30 WO disclosed
CN-103566026-B A kind of burn medicine and preparation method and application 窦霖 2016-08-03 CN disclosed
CN-103566026-A Burn medicament, and preparation method and application thereof DOU LIN 2014-02-12 CN disclosed
CN-1165673-A Quick effect compounded wet burn and scald prescription PENG YONGYAN (CN) 1997-11-26 CN disclosed